Regenicin, Inc.
Other OTCTotal Valuation
Regenicin, Inc. carries a market capitalization of 15,348.00, placing it among publicly traded companies globally.
| Market Cap | 15,348.00 |
| Enterprise Value | N/A |
Share Statistics
Regenicin, Inc. currently has 153.48M shares outstanding.
| Shares Outstanding | 153.48M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
| PE Ratio | N/A |
| PS Ratio | N/A |
| PB Ratio | -0.01 |
| P/TBV Ratio | -0.03 |
| P/FCF Ratio | -0.31 |
| P/OCF Ratio | -0.31 |
Financial Position
Regenicin, Inc. maintains a current ratio of 0.66, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.66 |
| Quick Ratio | 0.66 |
| Debt / Equity | N/A |
| Debt / EBITDA | N/A |
| Interest Coverage | -24.21 |
Financial Efficiency
| Return on Equity (ROE) | N/A |
| Return on Assets (ROA) | -15.72 |
| Return on Invested Capital (ROIC) | N/A |
| Return on Capital Employed (ROCE) | N/A |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | N/A |
Stock Price Statistics
Regenicin, Inc.'s stock has gained approximately 0.000003% over the past 52 weeks. The 50-day moving average sits at 0.00, while the 200-day moving average is 0.00.
| Beta (5Y) | N/A |
| 52-Week Price Change | 0.000003% |
| 50-Day Moving Average | 0.00 |
| 200-Day Moving Average | 0.00 |
| Average Volume (20 Days) | N/A |
Income Statement
EBITDA reached -894,589.00, while operating income came in at -894,589.00.
| Revenue | N/A |
| Gross Profit | N/A |
| Operating Income | -894,589.00 |
| Pretax Income | -932,437.00 |
| Net Income | -932,437.00 |
| EBITDA | -894,589.00 |
| EBIT | -894,589.00 |
| Earnings Per Share (EPS) | -0.01 |
Balance Sheet
Total book value stands at -16.42M, with working capital of -6.21M providing operational flexibility.
| Cash & Cash Equivalents | 11.86M |
| Total Debt | N/A |
| Net Debt | -10.24M |
| Equity (Book Value) | -16.42M |
| Book Value Per Share | -0.11 |
| Working Capital | -6.21M |
Cash Flow
Regenicin, Inc. produced -700,219.00 in operating cash flow over the past twelve months.
| Operating Cash Flow | -700,219.00 |
| Capital Expenditures | N/A |
| Free Cash Flow | -700,219.00 |
| FCF Per Share | 0.00 |
Dividends & Yields
The company's payout ratio of 5.37 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | N/A |
| Dividend Yield | N/A |
| Payout Ratio | 5.37 |
| Shareholder Yield | 444.45 |
| FCF Yield | -325.87 |
Scores
Regenicin, Inc. posts an Altman Z-Score of -2.83, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -2.83 |